Early reports show that subcutaneous injection of ovarian cancer cells transfected with either ILK-short hairpin RNA (shRNA) or ILK-antisense oligonucleotides (ASOs) suppresses tumor formation [15] and growth [16] in vivo. Here, ILK is linked to ovarian carcinoma.